144 related articles for article (PubMed ID: 12708570)
1. Tacrolimus in resistant primary membranous nephropathy--a report of 3 cases.
Szeto CC; Leung CB; Lai FM; Li PK
Clin Nephrol; 2003 Apr; 59(4):293-6. PubMed ID: 12708570
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
3. Success using tacrolimus in patients with proliferative and membranous lupus nephritis and refractory proteinuria.
Gordon S; Denunzio T; Uy A
Hawaii J Med Public Health; 2013 Sep; 72(9 Suppl 4):18-23. PubMed ID: 24052913
[TBL] [Abstract][Full Text] [Related]
4. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome.
Yuan H; Liu N; Sun GD; Jia Y; Luo P; Miao LN
Pharmacology; 2013; 91(5-6):259-66. PubMed ID: 23652322
[TBL] [Abstract][Full Text] [Related]
5. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial.
Praga M; Barrio V; Juárez GF; Luño J;
Kidney Int; 2007 May; 71(9):924-30. PubMed ID: 17377504
[TBL] [Abstract][Full Text] [Related]
7. Dermatomyositis associated with membranous nephropathy in a 43-year-old female.
Akashi Y; Inoh M; Gamo N; Kinashi M; Ohbayashi S; Miyake H; Kurata N
Am J Nephrol; 2002; 22(4):385-8. PubMed ID: 12169874
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
Peng L; Wei SY; Li LT; He YX; Li B
J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
11. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus.
Caro J; Gutiérrez-Solís E; Rojas-Rivera J; Agraz I; Ramos N; Rabasco C; Espinosa M; Valera A; Martín M; Frutos MÁ; Perea L; Juárez GF; Ocaña J; Arroyo D; Goicoechea M; Fernández L; Oliet A; Hernández Y; Romera A; Segarra A; Praga M;
Nephrol Dial Transplant; 2015 Mar; 30(3):467-74. PubMed ID: 25274748
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
13. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus.
Segarra-Medrano A; Jatem-Escalante E; Carnicer-Cáceres C; Agraz-Pamplona I; Salcedo MT; Valtierra N; Ostos-Roldán E; Arredondo KV; Jaramillo J
Nefrologia; 2014; 34(4):491-7. PubMed ID: 25036063
[TBL] [Abstract][Full Text] [Related]
14. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
[TBL] [Abstract][Full Text] [Related]
15. Profile and primary treatment outcomes in membranous nephropathy.
Hemanth Kumar MK; Sandhu J; Sandhu JS
Saudi Med J; 2022 Sep; 43(9):1051-1056. PubMed ID: 36104046
[TBL] [Abstract][Full Text] [Related]
16. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.
Tse KC; Lam MF; Tang SC; Tang CS; Chan TM
Lupus; 2007; 16(1):46-51. PubMed ID: 17283585
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tacrolimus-based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study.
Zhang XJ; Ji CF; Yuan JZ; Wang L; Zhang J; Fang W; Bai DF; Hu Z
Kaohsiung J Med Sci; 2019 Oct; 35(10):633-639. PubMed ID: 31225949
[TBL] [Abstract][Full Text] [Related]
18. Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
Cheng YJ; Cheng XY; Zhang YM; Wang F; Wang X; Meng LQ; Liu G; Cui Z; Zhao MH
J Nephrol; 2022 May; 35(4):1145-1157. PubMed ID: 34846713
[TBL] [Abstract][Full Text] [Related]
19. ACTH (corticotrophin) therapy in resistant primary membranous nephropathy.
Bagchi S; Behera V; Agarwal SK
Kidney Int; 2019 Jul; 96(1):250-251. PubMed ID: 31229041
[No Abstract] [Full Text] [Related]
20. Tacrolimus in membranous nephropathy.
Wetzels JF
Kidney Int; 2008 Jan; 73(2):238. PubMed ID: 18165814
[No Abstract] [Full Text] [Related]
[Next] [New Search]
